[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:optic-neuritis":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":34,"states":35},"Optic Neuritis",4,[7,15,21,28],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07623668","Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research",[11],"Phase 3","RECRUITING","2026-08-26T02:17:20.511551Z","2026-06-04T01:30:07.905699Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT07100990","Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)",[11],"2026-08-26T02:18:34.622081Z","2026-05-05T02:43:27.313723Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":26,"content_modified":27},"NCT02521311","Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)",[25],"Phase 2","2026-08-26T02:18:18.766496Z","2026-05-05T02:43:26.955206Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":32,"content_modified":33},"NCT06453694","Efgartigimod for the Treatment of Acute Optic Neuritis",[25],"2026-08-26T02:19:08.084946Z","2026-05-05T02:43:28.743664Z",[],[]]